Martin Shkreli Was Apparently Live Streaming When FBI Agents Called
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Glancy Prongay & Murray LLP Commences Investigation on Behalf of KaloBios Pharmaceuticals, Inc. Investors
December 17, 2015 1:53 PM ESTLOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP (GPM) is investigating potential claims on behalf of investors of KaloBios Pharmaceuticals, Inc. (KaloBios or the Company) (NASDAQ:... More
Nasdaq Halts KaloBios Pharmaceuticals, Inc.
December 17, 2015 10:41 AM ESTNEW YORK, Dec. 17, 2015 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) at 06:48:07 Eastern Time for "additional information requested" from the company at a last price of $23.59.
... More